Now, the gamechanger is obviously AI - transformative at most, if not all, levels of the business. Founders and businesses ...
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces the co-formulation of ASC36, a once-monthly next-generation amylin receptor agonist and ASC35, a once-monthly next-generation GLP-1R/GIPR dual ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果